Berman Capital Advisors’s Dentsply Sirona XRAY Stock Holding History

Berman Capital Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$53K	Sell	915 -253	-22%	-$15.6K	0.01%	658
2021 Q2	$73K	Buy	1,168 +479	+70%	+$31.6K	0.01%	457
2021 Q1	$44K	Buy	689 +34	+5%	+$1.97K	0.01%	529
2020 Q4	$34K	Buy	655 +256	+64%	+$12.6K	0.01%	515
2020 Q3	$17K	Buy	399 +248	+164%	+$11K	﹤0.01%	645
2020 Q2	$6K	Sell	151 -175	-54%	-$7.4K	﹤0.01%	956
2020 Q1	$12K	Sell	326 -16	-5%	-$815	﹤0.01%	631
2019 Q4	$19K	Buy	342 +43	+14%	+$2.4K	0.01%	558
2019 Q3	$15K	Hold	299	–	–	﹤0.01%	603
2019 Q2	$17K	Buy	299 +16	+6%	+$860	0.01%	569
2019 Q1	$14K	Buy	283 +132	+87%	+$5.81K	﹤0.01%	563
2018 Q4	$5K	Buy	+151	New	+$5.5K	﹤0.01%	707

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Berman Capital Advisors's XRAY Position: Q3 2021 in Review

Berman Capital Advisors reduced its Dentsply Sirona (XRAY) stake by 22% in Q3 2021, selling an estimated $15.6K and leaving 915 shares worth $53K. The position accounts for 0.01% of the portfolio, ranked #658.

Berman Capital Advisors first reported a position in XRAY in Q4 2018 and has held it in 12 quarters since. The position peaked at $73K in Q2 2021. 554 funds tracked by Wall St. Rank hold XRAY as of Q3 2021.

Berman Capital Advisors held 915 shares of Dentsply Sirona worth $53K as of Q3 2021.
Berman Capital Advisors sold 253 Dentsply Sirona shares in Q3 2021, an estimated $15.6K.
Dentsply Sirona made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #658 holding.
Berman Capital Advisors first reported a position in Dentsply Sirona in Q4 2018 and has held it in 12 quarters since.
Berman Capital Advisors's Dentsply Sirona position peaked at $73K in Q2 2021.
554 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.